Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.

Biogen has arrived at a highly unusual solution to a dispute surrounding a patent for its blockbuster multiple sclerosis drug Tecfidera. It has agreed to pay Denmark’s Forward Pharma $1.25 ...

Pre-Market: 5:58:06 a.m. EDT Loading Chart for BIIB ...

Partly cloudy. Slight chance of a shower early this evening. The chance of a thunderstorm early this evening. Light winds. Sun protection recommended from 9:40 am to 4:40 pm, UV Index predicted to ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Pre-market: 4:36:52 am GMT-5 ...

Dividend announcements are not available.